Health officials are considering a ban on two commonly prescribed weight loss injections, Saxenda and Wegovy, following growing concerns over their safety and long-term effects. The move could impact thousands of Britons relying on these treatments to manage obesity.
Why Are These Jabs Under Scrutiny?
The European Medicines Agency (EMA) has flagged potential risks associated with these medications, including thyroid tumours and pancreatitis. While the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has not yet confirmed a ban, experts urge caution.
What Are the Alternatives?
If Saxenda and Wegovy are restricted, patients may need to explore other options:
- Lifestyle changes: Diet and exercise remain the most sustainable methods for weight loss.
- Alternative medications: Other approved drugs, such as Orlistat, may be recommended.
- Surgical options: Bariatric surgery could be considered for severe cases.
What’s Next?
The MHRA is expected to review the evidence and make a final decision in the coming months. Patients currently using these jabs are advised to consult their GP before making any changes to their treatment.
